CXCR1 and diabetes mellitus: A relationship between CXCR1/2 chemokine receptors and the advancement of insulitis and diabetes in mice has been previously established, demonstrating that transient CXCR1/2 inhibition inhibits inflammation-mediated islet impairment in the mild streptozotocin models [24].